Literature DB >> 25553378

Andrographolide and analogues in cancer prevention.

Siddhartha Kumar Mishra1, Swati Tripathi1, Archana Shukla1, Seung Hyun Oh1, Hwan Mook Kim1.   

Abstract

Andrographis paniculata is a medicinal plant traditionally used for treatment of cough and cold, fever, laryngitis, and several infectious diseases. Extracts of A. paniculata have shown versatile potency against various diseases including cancer. The active biomolecules of A. paniculata mainly are lactone and diterpene. Andrographolide and analogues have been widely used for prevention of different diseases. Andrographolides have shown potent antiinflammatory and anticancer activities. It showed potentials as chemopreventive agents by suppressing growth of cancer cells by inhibiting NF-kappaB, PI3K/AKT and other kinase pathways and by inducing apoptosis. Andrographolide induced both intrinsic and extrinsic apoptosis pathway in different cancer cells via expression of different anti-apoptotic protein like Bax, p53, and activated caspases. Andrographolide was successfully used as an antineoplastic drug in cancer chemotherapy. Andrographolide inhibited the growth of human breast, prostate, and hepatoma tumors. Andrographolide and analogues need to be subjected to further clinical and biomedical studies in cancer chemoprevention. Andrographolide could be potent anticancer agent when used in combination with other chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25553378     DOI: 10.2741/E732

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  15 in total

1.  Andrographolide: antibacterial activity against common bacteria of human health concern and possible mechanism of action.

Authors:  Malabika Banerjee; Debaprasad Parai; Subrata Chattopadhyay; Samir Kumar Mukherjee
Journal:  Folia Microbiol (Praha)       Date:  2017-01-17       Impact factor: 2.099

2.  Andrographolide induces anti-SARS-CoV-2 response through host-directed mechanism: an in silico study.

Authors:  Bhabani Shankar Das; Nabarun Chandra Das; Shasank Sekhar Swain; Suprabhat Mukherjee; Debapriya Bhattacharya
Journal:  Future Virol       Date:  2022-07-04       Impact factor: 3.015

3.  Andrographolide inhibits proliferation and induces cell cycle arrest and apoptosis in human melanoma cells.

Authors:  Guo Liu; Haihan Chu
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

4.  Design, synthesis and discovery of andrographolide derivatives against Zika virus infection.

Authors:  Feng Li; Emily M Lee; Xia Sun; Decai Wang; Hengli Tang; Guo-Chun Zhou
Journal:  Eur J Med Chem       Date:  2019-11-30       Impact factor: 6.514

Review 5.  Natural and Synthetic Lactones Possessing Antitumor Activities.

Authors:  Younghoon Kim; Sandip Sengupta; Taebo Sim
Journal:  Int J Mol Sci       Date:  2021-01-21       Impact factor: 6.208

6.  Andrographolide Inhibits Cholangiocarcinoma Cell Migration by Down-Regulation of Claudin-1 via the p-38 Signaling Pathway.

Authors:  Phorutai Pearngam; Supeecha Kumkate; Seiji Okada; Tavan Janvilisri
Journal:  Front Pharmacol       Date:  2019-07-25       Impact factor: 5.810

7.  Quantitative Determination of Andrographolide and Related Compounds in Andrographis paniculata Extracts and Biological Evaluation of Their Anti-Inflammatory Activity.

Authors:  Emmanuelle Villedieu-Percheron; Véronique Ferreira; Joana Filomena Campos; Emilie Destandau; Chantal Pichon; Sabine Berteina-Raboin
Journal:  Foods       Date:  2019-12-14

8.  Andrographolide sensitizes prostate cancer cells to TRAIL-induced apoptosis.

Authors:  Ruo-Jing Wei; Xin-Shi Zhang; Da-Lin He
Journal:  Asian J Androl       Date:  2018 Mar-Apr       Impact factor: 3.285

Review 9.  Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy.

Authors:  Sankhadip Bose; Sabyasachi Banerjee; Arijit Mondal; Utsab Chakraborty; Joshua Pumarol; Courtney R Croley; Anupam Bishayee
Journal:  Cells       Date:  2020-06-11       Impact factor: 6.600

10.  Andrographolide Ameliorates Diabetic Cardiomyopathy in Mice by Blockage of Oxidative Damage and NF-κB-Mediated Inflammation.

Authors:  Ershun Liang; Xue Liu; Zhanhui Du; Ruixue Yang; Yuxia Zhao
Journal:  Oxid Med Cell Longev       Date:  2018-06-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.